AMACR


Also found in: Acronyms, Wikipedia.

AMACR

Alpha-Methylacyl coenzyme A racemase. An enzyme involved in beta-oxidation of branched-chain fatty acids, the gene for which is overexpressed in certain cancers, in particular prostate.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

AMACR

alpha-Methylacyl-CoA racemase.
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
Positive markers for lung primary and negative staining for CD10, PAX8, CA19.9, CD57 and AMACR excluded the renal, pancreas and prostate primary respectively.
Conclusion: As the mutation was found in the healthy samples as well, it can be said that the current mutation AMACR can be involved in some other forms of peripheral neuropathy which can be with other phenotypes.
Caption: Figure 10: P504S (AMACR) immunostain was focally positive in the tumor cells.
Results: Out of the total 80 cases, 68 (85%) were positive for AMACR while 12 (15%) were negative.
The most common adenocarcinomas metastatic to the bladder are from the prostate, therefore, markers PSA (prostate specific antigen) and AMACR (alpha-methylacyl-CoA racemase) which are positive for prostate origin, were performed.
Interpretation of AMACR staining- Positive staining is indicated by brownish cytoplasmic staining of 80-100% of tumour cells in tissue sections.
The positive AMACR staining was described by continuous, dark red cytoplasmic staining or apical granular staining patterns in the malignant epithelial cells that could be observed easily at low-power magnification (<100x), whereas 34[beta]E12 and p63 were considered positive by dark brown cytoplasmic and nuclear staining in the basal cells respectively.
Results: AMACR expression were found in 58 (90.6 Percent) and iNOS expression in 54 (84.4 Percent) of 64 prostate adenocarcinomas.
Immunhistokimyasal calismada, adenom odaklarinda alpha-methyacyl Ccoenzyme A racemase (AMACR) (Clone 13H4, Thermoscientific, CA, USA) ve sitokeratin 7 (Clone OV-TL12/30, Neomarkers, CA, USA) "pozitif" boyandi (Resim 3).
A plethora of promising blood- and urine-based biomarkers have shown promise in early studies and are at various stages of development (Human kallikrein 2, Early Prostate Cancer Antigen, Transforming Growth Factor-Beta 1 and Interleukin-6, Endoglin, PCA3, AMACR and ETS Gene Fusions).
This list included known prostate cancer biomarkers such as PSA, [alpha]-methylacyl-CoA racemase (AMACR), and kallikrein-related pepsidase 2 (KLK2).